← Back to home

Adult acute promyelocytic leukemia with T(15;17)(Q24.1;Q21.2); PML-rara

Clinical trials for Adult acute promyelocytic leukemia with T(15;17)(Q24.1;Q21.2); PML-rara explained in plain language.

Never miss a new study

Get alerted when new Adult acute promyelocytic leukemia with T(15;17)(Q24.1;Q21.2); PML-rara trials appear

Sign up with your email to follow new studies for Adult acute promyelocytic leukemia with T(15;17)(Q24.1;Q21.2); PML-rara, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

Experimental drug pair targets tough leukemias

Disease control Completed

This early-phase trial tested a combination of two drugs—veliparib and temozolomide—in 66 adults with relapsed or refractory acute leukemias. Veliparib blocks a DNA repair enzyme, while temozolomide damages cancer cell DNA. The goal was to find the safest dose and check for side …

Matched conditions: ADULT ACUTE PROMYELOCYTIC LEUKEMIA WITH T(15;17)(Q24.1;Q21.2); PML-RARA

Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jun 27, 2026 07:58 UTC

Adult acute promyelocytic leukemia with T(15;17)(Q24.1;Q21.2); PML-rara

Get alerted when new Adult acute promyelocytic leukemia with T(15;17)(Q24.1;Q21.2); PML-rara trials appear

Experimental drug pair targets tough leukemias